|
Eingeschlafen hier..dabei Supernews! + 157% in NY! ThermoElastic Technologies, Inc. Announces the Completion Of New BITEM Submissions to FDA and Confirmation That DISIFIN Is Effective in Killing Anthrax TORONTO, Oct. 29 /PRNewswire/ -- ThermoElastic Technologies, Inc (OTC Bulletin Board: TMRO) is pleased to announce that the European developer of DISIFIN has advised TMRO that current testing of DISIFIN confirms that solutions as low as 0.05% of DISIFIN kills ANTHRAX active status bacteria as well as all other gram positive and gram negative bacteria found on hard surfaces such as those found in hospital, health care facilities, food processing plants, animal farms, health clubs hotels and homes. Presently, the Company is working to complete the required testing to meet the EPA requirements for its DISIFIN solid disinfectant products and expects to be submitting the completed EPA Application for DISIFIN early in the new year. The Company is also pleased to announce that the additional testing required by the FDA for the 510K approval process for the uses of BITEM (Biocompatible Intraoral Thermo Elastic Material) Dental Products that were not previously approved has been completed and the new 510K Application for these BITEM Dental Products was submitted to the FDA during the last week of August, 2001. FDA Approval is expected by the end of November or early December 2001 and will enable TMRO to launch the sale of BITEM Dental Products in the United States. In Europe and the Middle East BITEM is now being distributed and sold in twelve (12) countries including England, Italy, Greece, Austria, Czech Republic, Slovakia, The Netherlands, Belgium, Luxembourg, Spain, Portugal and Israel. TMRO anticipates that the worldwide sales of its BITEM Products and sales in the US and Canada of DISIFIN Products in the 12 months following receipt of all pending FDA Applications will reach $10,000,000 to $12,000,000. Dental distribution in the United States has been organized through Zahn Dental, a Henry Schein Company. The Company will commence delivery of BITEM Dental Products for sale in the United States from existing inventories as soon as FDA Approval has been received. (This news release includes statements that may constitute forward-looking statements under the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are necessary estimates reflecting the best judgment of the party making such statements based upon current information and involve a number of risks and uncertainties. Forward-looking statements contained in this press release or in other public statements of ThermoElastic Technologies, Inc should be considered in light of those factors. Although ThermoElastic Technologies, Inc. believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be met.) |
|
| aus der Diskussion: | Neu an der OTC! TMRO |
| Autor (Datum des Eintrages): | BII-Aktionär (29.10.01 19:23:07) |
| Beitrag: | 19 von 25 (ID:4748360) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |